Rheological comparison of sputum and reconstituted airway epithelium mucus
- PMID: 39738355
- PMCID: PMC11685952
- DOI: 10.1038/s41598-024-80932-y
Rheological comparison of sputum and reconstituted airway epithelium mucus
Abstract
Pulmonary mucus serves as a crucial protective barrier in the respiratory tract, defending against pathogens and contributing to effective clearance mechanisms. In Muco Obstructive Pulmonary Diseases (MOPD), abnormal rheological properties lead to highly viscous mucus, fostering chronic infections and exacerbations. While prior research has linked mucus viscoelasticity to its mucin content, the variability in MOPD patients implies the involvement of other factors. To isolate these effects, mucus produced by epithelia reconstituted in vitro serves as a powerful versatile model for mucin research. This study characterises the rheology of mucus collected from Air-Liquid Interface (ALI) cultures and compares it to sputum samples from MOPD patients, demonstrating that macrorheology with cone-plate geometries is a reproducible method for analysing small mucus quantities from ALI cultures. While sputum samples exhibit similarities in rigidity with ALI mucus, they also display structural differences and variations in their response to substantial deformations. The study highlights the importance of understanding mucus behaviour under large deformations, emphasising the role of ALI cultures as a controlled environment for conducting detailed studies.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: L.E.E., V.T.P. and J.P. are full time employees of Rheonova, the company which designs and produces the rheometer used in this study. M.B., H.S. and S.C. are full time employees of Epithelix, the company producing the ALI cultures.
Figures




Similar articles
-
Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases.Biomater Sci. 2024 Aug 20;12(17):4376-4385. doi: 10.1039/d4bm00381k. Biomater Sci. 2024. PMID: 39028033
-
Mucins, mucus, and sputum.Chest. 2009 Feb;135(2):505-512. doi: 10.1378/chest.08-0412. Chest. 2009. PMID: 19201713 Review.
-
An optimized protocol for assessment of sputum macrorheology in health and muco-obstructive lung disease.Front Physiol. 2022 Aug 5;13:912049. doi: 10.3389/fphys.2022.912049. eCollection 2022. Front Physiol. 2022. PMID: 35991170 Free PMC article.
-
Nanoscale Viscometry Reveals an Inherent Mucus Defect in Cystic Fibrosis.ACS Nano. 2025 Feb 4;19(4):4637-4649. doi: 10.1021/acsnano.4c14927. Epub 2025 Jan 18. ACS Nano. 2025. PMID: 39825840
-
Mucus, phlegm, and sputum in cystic fibrosis.Respir Care. 2009 Jun;54(6):726-32; discussion 732. doi: 10.4187/002013209790983269. Respir Care. 2009. PMID: 19467160 Review.
Cited by
-
Establishing a Xanthan Gum-Locust Bean Gum Mucus Mimic for Cystic Fibrosis Models: Yield Stress and Viscoelasticity Analysis.Biomimetics (Basel). 2025 Apr 17;10(4):247. doi: 10.3390/biomimetics10040247. Biomimetics (Basel). 2025. PMID: 40277645 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources